Klemz Kevin M 4
4 · Silk Road Medical Inc · Filed Mar 5, 2024
Insider Transaction Report
Form 4
Klemz Kevin M
EVP/Chief Legal Officer/Sec.
Transactions
- Award
Common Stock
2024-03-01+42,818→ 167,691 total - Sale
Common Stock
2024-03-05$17.17/sh−2,497$42,871→ 165,194 total
Footnotes (2)
- [F1]The reported securities are represented by restricted stock units ("RSUs"), each of which represents a contingent right to receive one share of SILK common stock. 25% of the shares shall vest on March 1, 2025 and each one-year anniversary thereafter, subject to the Reporting Person continuing as a service provider through each such date.
- [F2]Represents shares that have been sold by the Reporting Person to satisfy income tax withholding and remittance obligations in connection with the vesting and net settlement of restricted stock units previously reported.